Medicine Prices in India May Rise as Key Pharma Ingredients Surge 30% Amid Shipping Disruptions

Medicine prices in India may increase significantly after the cost of key pharmaceutical ingredients surged nearly 30% in the past two weeks, according to industry sources. The spike is largely linked to shipping disruptions and container shortages triggered by the ongoing Iran-related geopolitical tensions. Many Indian drug manufacturers depend heavily on China for active pharmaceutical ingredients (APIs) and other raw materials. However, shortages of container vessels have slowed the movement of these essential inputs, affecting supply chains and raising production costs for pharmaceutical companies. Industry officials say importers are already passing higher costs to large pharmaceutical companies, as prices of APIs and solvents have risen sharply. In some cases, raw materials like glycerine have jumped over 60%, while paracetamol prices have increased around 26% since December. Experts warn that if the geopolitical tensions continue, shipping routes could remain disrupted, pushing logistics costs even higher and eventually impacting the availability and pricing of essential medicines in India. The pharmaceutical industry has urged regulators to allow temporary price increases to offset the sudden surge in input costs.